Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.5350
+0.0700 (15.05%)
Aug 1, 2025, 4:00 PM - Market closed

Rallybio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
224090249307-
Upgrade
Market Cap Growth
-61.07%-55.91%-63.67%-18.90%--
Upgrade
Enterprise Value
-32-35-31117120-
Upgrade
Last Close Price
0.540.962.396.579.54-
Upgrade
PS Ratio
28.1062.62----
Upgrade
PB Ratio
0.410.650.851.471.75-
Upgrade
P/TBV Ratio
0.410.650.851.471.75-
Upgrade
Debt / Equity Ratio
0.000.000.000.00--
Upgrade
Asset Turnover
0.010.01----
Upgrade
Quick Ratio
13.9410.5011.8715.7326.7624.00
Upgrade
Current Ratio
14.6810.8712.3916.7127.6124.18
Upgrade
Return on Equity (ROE)
-67.28%-68.85%-54.13%-38.65%-30.18%-34.60%
Upgrade
Return on Assets (ROA)
-40.02%-38.91%-33.33%-23.40%-17.61%-19.35%
Upgrade
Return on Capital (ROIC)
-43.83%-42.46%-35.69%-24.56%-18.31%-20.69%
Upgrade
Earnings Yield
-216.43%-145.06%-82.55%-26.81%-15.34%-
Upgrade
FCF Yield
-197.77%-123.74%-66.73%-23.06%-14.96%-
Upgrade
Buyback Yield / Dilution
-9.78%-7.66%-27.11%-24.70%-46.76%-913.79%
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q